TY - STD TI - Noserworthy J, Miller D, Compston A. Disease-modifying treatments in multiple sclerosis. In: Compaston A, et al, editors. McAlpine’s Multiple sclerosis. 4th ed. Churchill Livingstone, Elsevier; 2006. p. 729–802 ID - ref1 ER - TY - JOUR AU - Giovannoni, G. AU - Turner, B. AU - Gnanapavan, S. AU - Offiah, C. PY - 2015 DA - 2015// TI - Is it time to target no evident disease activity (NEDA) in multiple sclerosis? JO - Mult Scler Relat Disord VL - 4 UR - https://doi.org/10.1016/j.msard.2015.04.006 DO - 10.1016/j.msard.2015.04.006 ID - Giovannoni2015 ER - TY - JOUR AU - Rotstein, D. L. AU - Healy, B. C. AU - Malik, M. T. AU - Chitnis, T. AU - Weiner, H. L. PY - 2015 DA - 2015// TI - Evaluation of no evidence of disease activity in a 7-year longitudinal multiple sclerosis cohort JO - JAMA Neurol VL - 72 UR - https://doi.org/10.1001/jamaneurol.2014.3537 DO - 10.1001/jamaneurol.2014.3537 ID - Rotstein2015 ER - TY - JOUR AU - Stefano, N. AU - Stromillo, M. L. AU - Giorgio, A. AU - Battaglini, M. AU - Bartolozzi, M. L. AU - Amato, M. P. AU - Sormani, M. P. PY - 2015 DA - 2015// TI - Long-term assessment of no evidence of disease activity in relapsing-remitting MS JO - Neurology VL - 85 UR - https://doi.org/10.1212/WNL.0000000000002105 DO - 10.1212/WNL.0000000000002105 ID - Stefano2015 ER - TY - JOUR AU - Boyko, A. AU - Davidovskaya, V. AU - Deomina, T. PY - 2005 DA - 2005// TI - Clinical results of 3 year experience of Copaxone® in RRMS patients from the Moscow MS Center JO - Mult Scler VL - 11 ID - Boyko2005 ER - TY - JOUR AU - Boyko, A. N. AU - Davidovskaya, M. V. AU - Demina, T. L. PY - 2007 DA - 2007// TI - Results of the use of Copaxone and Betaferon in Moscow MS Center: analysis the clinical effects of 5-years of therapy in every day practice in Moscow MC Center JO - Korsakov’a J Neurol Psychiatr VL - 4 ID - Boyko2007 ER - TY - JOUR AU - Boyko, A. N. AU - Davydovskaya, M. V. AU - Demina, T. L. PY - 2013 DA - 2013// TI - Efficacy and tolerance of glatiramer acid (Copaxone) on long-term use: 10 Years of experience at the Moscow City Multiple Sclerosis Center JO - Neurosci Behav Physiol VL - 43 UR - https://doi.org/10.1007/s11055-013-9773-5 DO - 10.1007/s11055-013-9773-5 ID - Boyko2013 ER - TY - JOUR AU - Poser, C. M. AU - Paty, D. W. AU - Scheinberg, L. PY - 1983 DA - 1983// TI - New diagnostic criteria for multiple sclerosis: guidellines for research protocols JO - Ann Neurol VL - 13 UR - https://doi.org/10.1002/ana.410130302 DO - 10.1002/ana.410130302 ID - Poser1983 ER - TY - JOUR AU - Ford, C. C. PY - 2006 DA - 2006// TI - Long-term experience with current disease-modifying drugs in multiple sclerosis JO - J Neurol VL - 253 ID - Ford2006 ER - TY - JOUR AU - Johnson, K. P. AU - Brooks, B. R. AU - Ford, C. C. PY - 2000 DA - 2000// TI - Sustained clinical benefits of glatiramer acetate in relapsing multiple sclerosis patients observed for 6 years JO - Mult Scler VL - 6 UR - https://doi.org/10.1177/135245850000600407 DO - 10.1177/135245850000600407 ID - Johnson2000 ER - TY - JOUR AU - Johnson, K. P. AU - Ford, C. C. AU - Lisak, R. P. AU - Wolinsky, J. S. PY - 2005 DA - 2005// TI - Neurologic consequence of delaying glatiramer acetate therapy for multiple sclerosis: 8-year data JO - Acta Neurol Scand VL - 111 UR - https://doi.org/10.1111/j.1600-0404.2004.00351.x DO - 10.1111/j.1600-0404.2004.00351.x ID - Johnson2005 ER - TY - JOUR AU - Wolinsky, J. S. AU - Narayana, P. A. AU - Johnson, K. P. PY - 2001 DA - 2001// TI - United States open-label glatiramer acetate extension trial for relapsing multiple sclerosis: MRI and clinical correlates JO - Mult Scler VL - 7 UR - https://doi.org/10.1177/135245850100700107 DO - 10.1177/135245850100700107 ID - Wolinsky2001 ER - TY - JOUR AU - Karussis, D. AU - Biermann, L. D. AU - Bohlega, S. PY - 2006 DA - 2006// TI - A recommended treatment algorithm in relapsing multiple sclerosis: report of an international consensus meeting JO - Europ J Neurol VL - 13 UR - https://doi.org/10.1111/j.1468-1331.2006.01147.x DO - 10.1111/j.1468-1331.2006.01147.x ID - Karussis2006 ER - TY - STD TI - Kappos L, Kuhle J, Multanen J, et al. Factors influencing long-term outcomes in relapsing-remitting multiple sclerosis: PRISMS-15. J Neurol Neurosurg Psychiatry. 2015;86(11):1202–7. ID - ref14 ER -